Structured Content

Understanding structured content: definition and benefits

In today’s digital age, the way we manage and utilize information has evolved dramatically. Conventionally, document content is unstructured, with text, figures, and tables that authors can freely arrange in the way they want to. By structuring content, we can shift from a document-based to a content and data-based approach. But what exactly is structured […]

Understanding structured content: definition and benefits Read More »

Standardize and Harmonize Product Information with Fonto: Advancing the ePI Initiative

In the ever-evolving landscape of pharmaceutical regulations and information management, the need to standardize and harmonize product information has become increasingly crucial. At the forefront of this movement is the Swedish Medical Products Agency, Läkemedelsverket, which has recently made significant strides with their ePI (electronic Product Information) Proof of Concept. In this post, we’re sharing

Standardize and Harmonize Product Information with Fonto: Advancing the ePI Initiative Read More »

The importance of structured content in an AI-driven world

Discover the power of structured content in the realm of generative pre-trained transformers (GPT), the groundbreaking technology revolutionizing language models. In this article, we’ll focus on how structured content enhances the training process, leading to easier data processing, improved accuracy, and enriched contextual understanding. While unstructured content has its merits, we’ll explore why a balanced

The importance of structured content in an AI-driven world Read More »

Update on national pilot study for pharmaceutical companies creating ePI

In 2022, the Swedish Medical Products Agency (Swedish MPA) selected Fonto as the editor of choice for the creation of electronic structured SmPC’s. Over the past few months, the Swedish MPA has developed an XML template adapted for Fonto. Electronic product information In a Proof-of-Concept model, information elements are divided into categories depending on the

Update on national pilot study for pharmaceutical companies creating ePI Read More »

The Future of Standards: the ISO Annual Meeting 2022

We are present at ISO’s Annual Meeting, a meeting for all standards developing bodies worldwide. For the first time this year, the event is open to other organizations and companies that work with standards developing bodies. Against the spectacular backdrop of downtown Abu Dhabi, four full days of meetings, discussions and networking events are taking

The Future of Standards: the ISO Annual Meeting 2022 Read More »

Structured content for pharma

It takes pharma companies about five times longer to create content, compared to other industries. Delayed drug approvals turn into an average loss of $1 million dollars per day for pharma companies. Val Swisher and Regina Lynn Preciado from Content Rules recently published an interesting e-book: “Structured Content for Pharma – Making the Case for

Structured content for pharma Read More »

Moving from Word: why changing the interface is unacceptable

In pharma—and many other industries, too—Microsoft Word is the tool to create content. It’s the natural environment for many subject-matter experts to write, edit and review content. Every author is familiar with the Word interface. But it’s not structured content that’s created … “We cannot change the authoring experience” Forcing subject-matter experts, for example medical

Moving from Word: why changing the interface is unacceptable Read More »

Global Pharmaceutical Regulatory Affairs Summit: Structured Content and Integrated Data

Today, Jan Benedictus presented at the Global Pharmaceutical Regulatory Affairs Summit 2022 in Berlin: “The Future of Documents: Structured Content, Integrated Data”. Global Pharmaceutical Regulatory Affairs Summit The Global Pharmaceutical Regulatory Affairs Summit focuses on the challenges of IDMP, RIM, eSubmissions and Global Market Regulation in the pharmaceutical industry. The Future of Documents The Future

Global Pharmaceutical Regulatory Affairs Summit: Structured Content and Integrated Data Read More »

Scroll to Top